Resistance To COVID-19 Vaccine Running So High It Would Twart Efforts To Reach Community Immunity – New Study 20/10/2020 Madeleine Hoecklin Current levels of public reluctance to be immunized with a forthcoming COVID-19 vaccine are so high that the resistance would in fact pre-empt many countries from reaching sufficient levels of “community” immunity, according to a new study of vaccine hesitancy among people in 19 of the most COVID-impacted countries around the world. The study of […] Continue reading -> Pfizer Won’t Pursue Emergency Authorization for COVID-19 Vaccine Before Mid-November, Says CEO in Open Letter 16/10/2020 Madeleine Hoecklin Pfizer CEO, Albert Bourla, announced Friday in an open letter that the pharmaceutical company developing a COVID-19 vaccine will not request an emergency authorization before mid-November – meaning that the file of the vaccine candidate that is regarded as the front-runner in the global race to get a vaccine to market would only be reviewed […] Continue reading -> Much-Touted Remdesivir Fails To Reduce COVID-19 Deaths; Results Of WHO-Coordinated Solidarity Trial 16/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin Two more experimental COVID-19 drugs, including the much-touted Remdesivir, appear to have fallen by the wayside, failing to show significant reductions in mortality among seriously ill patients. Interim results on Remdesivir and three other drug treatments being studied as part of the WHO Solidarity Therapeutics Trial, the world’s largest randomized controlled trial of COVID-19 drugs, […] Continue reading -> Ratification of Africa Medicines Agency Treaty Inches Forward – Africa CDC Head Calls It ‘Much-Needed’ 16/10/2020 Paul Adepoju IBADAN, Nigeria – Nearly two years after the Assembly of the African Union, adopted a milestone treaty establishing an African Medicines Agency (AMA) that could provide a more unified approach to regulatory approval of new medicines and vaccines, the AMA treaty is yet to enter into force – because it has not been ratified by […] Continue reading -> China’s Inactivated COVID-19 Vaccine Candidate Is Safe and Provokes Immune Response, Say Preliminary Clinical Trial Results 16/10/2020 Madeleine Hoecklin A new study published in The Lancet on Thursday found that an inactivated vaccine candidate, called BBIBP-CorV, was safe and provoked an immune response in healthy individuals. This is the first study of an inactivated COVID-19 vaccine to include participants over 60 years of age. The BBIBP-CorV vaccine is being developed by the Beijing Institute of […] Continue reading -> World Trade Organization Enters COVID Pandemic Fray With Dispute Brewing Over Patent Rights 14/10/2020 Elaine Ruth Fletcher A safe, proven vaccine for COVID-19 doesn’t yet exist. But the battle for access is heating up. Even as the world struggles to come up with a viable COVID-19 vaccine as well as new treatments, the debate over how to ensure that people around the world can get access to whatever products are available, now […] Continue reading -> The Indian/South African Proposal For a WTO Waiver On IP For COVID-19 Related Health Products – What It Means? 14/10/2020 Ellen 't Hoen A sweeping proposal by India and South Africa to suspend the protection of intellectual property (IP) related to COVID-19 health products is set to come before the The World Trade Organization’s TRIPS Council this week. The closed door discussion lays the groundwork for what could prove to be the most significant public debate over […] Continue reading -> Urgent Action Needed To End Tuberculosis By 2030, Concludes WHO’s Global Tuberculosis Report 14/10/2020 Svĕt Lustig Vijay The world must take urgent action to end the global tuberculosis epidemic by 2030, especially as the pandemic threatens to unwind hard-won progress made in past decades, concluded the WHO’s 2020 Global Tuberculosis Report on Wednesday. While the WHO European region is on track to achieve key 2020 targets, the rest of the world has […] Continue reading -> Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment 13/10/2020 Editorial team Illustration of the AdVac® adenovirus technology, being tested by Johnson & Johnson, (Credit: J&J) Johnson & Johnson, the only pharma firm currently developing a one-dose COVID-19 vaccine candidate, has “paused” its Phase 3 clinical trial due to an unexplained illness in one of the participants. A press release issued on Monday confirmed reports that a […] Continue reading -> China, Republic of Korea Join COVAX Global Vaccine Pool – WHO Urges Countries To Jumpstart Vaccine Campaigns 09/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin China has announced that it will join the WHO co-sponsored COVAX vaccine procurement pool, along with the Republic of Korea. WHO’s Director General Dr Tedros described it as a major boost to the global effort to manufacture and distribute 2 billion vaccines worldwide equitably by the end of 2021. “This week, China and the Republic […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pfizer Won’t Pursue Emergency Authorization for COVID-19 Vaccine Before Mid-November, Says CEO in Open Letter 16/10/2020 Madeleine Hoecklin Pfizer CEO, Albert Bourla, announced Friday in an open letter that the pharmaceutical company developing a COVID-19 vaccine will not request an emergency authorization before mid-November – meaning that the file of the vaccine candidate that is regarded as the front-runner in the global race to get a vaccine to market would only be reviewed […] Continue reading -> Much-Touted Remdesivir Fails To Reduce COVID-19 Deaths; Results Of WHO-Coordinated Solidarity Trial 16/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin Two more experimental COVID-19 drugs, including the much-touted Remdesivir, appear to have fallen by the wayside, failing to show significant reductions in mortality among seriously ill patients. Interim results on Remdesivir and three other drug treatments being studied as part of the WHO Solidarity Therapeutics Trial, the world’s largest randomized controlled trial of COVID-19 drugs, […] Continue reading -> Ratification of Africa Medicines Agency Treaty Inches Forward – Africa CDC Head Calls It ‘Much-Needed’ 16/10/2020 Paul Adepoju IBADAN, Nigeria – Nearly two years after the Assembly of the African Union, adopted a milestone treaty establishing an African Medicines Agency (AMA) that could provide a more unified approach to regulatory approval of new medicines and vaccines, the AMA treaty is yet to enter into force – because it has not been ratified by […] Continue reading -> China’s Inactivated COVID-19 Vaccine Candidate Is Safe and Provokes Immune Response, Say Preliminary Clinical Trial Results 16/10/2020 Madeleine Hoecklin A new study published in The Lancet on Thursday found that an inactivated vaccine candidate, called BBIBP-CorV, was safe and provoked an immune response in healthy individuals. This is the first study of an inactivated COVID-19 vaccine to include participants over 60 years of age. The BBIBP-CorV vaccine is being developed by the Beijing Institute of […] Continue reading -> World Trade Organization Enters COVID Pandemic Fray With Dispute Brewing Over Patent Rights 14/10/2020 Elaine Ruth Fletcher A safe, proven vaccine for COVID-19 doesn’t yet exist. But the battle for access is heating up. Even as the world struggles to come up with a viable COVID-19 vaccine as well as new treatments, the debate over how to ensure that people around the world can get access to whatever products are available, now […] Continue reading -> The Indian/South African Proposal For a WTO Waiver On IP For COVID-19 Related Health Products – What It Means? 14/10/2020 Ellen 't Hoen A sweeping proposal by India and South Africa to suspend the protection of intellectual property (IP) related to COVID-19 health products is set to come before the The World Trade Organization’s TRIPS Council this week. The closed door discussion lays the groundwork for what could prove to be the most significant public debate over […] Continue reading -> Urgent Action Needed To End Tuberculosis By 2030, Concludes WHO’s Global Tuberculosis Report 14/10/2020 Svĕt Lustig Vijay The world must take urgent action to end the global tuberculosis epidemic by 2030, especially as the pandemic threatens to unwind hard-won progress made in past decades, concluded the WHO’s 2020 Global Tuberculosis Report on Wednesday. While the WHO European region is on track to achieve key 2020 targets, the rest of the world has […] Continue reading -> Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment 13/10/2020 Editorial team Illustration of the AdVac® adenovirus technology, being tested by Johnson & Johnson, (Credit: J&J) Johnson & Johnson, the only pharma firm currently developing a one-dose COVID-19 vaccine candidate, has “paused” its Phase 3 clinical trial due to an unexplained illness in one of the participants. A press release issued on Monday confirmed reports that a […] Continue reading -> China, Republic of Korea Join COVAX Global Vaccine Pool – WHO Urges Countries To Jumpstart Vaccine Campaigns 09/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin China has announced that it will join the WHO co-sponsored COVAX vaccine procurement pool, along with the Republic of Korea. WHO’s Director General Dr Tedros described it as a major boost to the global effort to manufacture and distribute 2 billion vaccines worldwide equitably by the end of 2021. “This week, China and the Republic […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Much-Touted Remdesivir Fails To Reduce COVID-19 Deaths; Results Of WHO-Coordinated Solidarity Trial 16/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin Two more experimental COVID-19 drugs, including the much-touted Remdesivir, appear to have fallen by the wayside, failing to show significant reductions in mortality among seriously ill patients. Interim results on Remdesivir and three other drug treatments being studied as part of the WHO Solidarity Therapeutics Trial, the world’s largest randomized controlled trial of COVID-19 drugs, […] Continue reading -> Ratification of Africa Medicines Agency Treaty Inches Forward – Africa CDC Head Calls It ‘Much-Needed’ 16/10/2020 Paul Adepoju IBADAN, Nigeria – Nearly two years after the Assembly of the African Union, adopted a milestone treaty establishing an African Medicines Agency (AMA) that could provide a more unified approach to regulatory approval of new medicines and vaccines, the AMA treaty is yet to enter into force – because it has not been ratified by […] Continue reading -> China’s Inactivated COVID-19 Vaccine Candidate Is Safe and Provokes Immune Response, Say Preliminary Clinical Trial Results 16/10/2020 Madeleine Hoecklin A new study published in The Lancet on Thursday found that an inactivated vaccine candidate, called BBIBP-CorV, was safe and provoked an immune response in healthy individuals. This is the first study of an inactivated COVID-19 vaccine to include participants over 60 years of age. The BBIBP-CorV vaccine is being developed by the Beijing Institute of […] Continue reading -> World Trade Organization Enters COVID Pandemic Fray With Dispute Brewing Over Patent Rights 14/10/2020 Elaine Ruth Fletcher A safe, proven vaccine for COVID-19 doesn’t yet exist. But the battle for access is heating up. Even as the world struggles to come up with a viable COVID-19 vaccine as well as new treatments, the debate over how to ensure that people around the world can get access to whatever products are available, now […] Continue reading -> The Indian/South African Proposal For a WTO Waiver On IP For COVID-19 Related Health Products – What It Means? 14/10/2020 Ellen 't Hoen A sweeping proposal by India and South Africa to suspend the protection of intellectual property (IP) related to COVID-19 health products is set to come before the The World Trade Organization’s TRIPS Council this week. The closed door discussion lays the groundwork for what could prove to be the most significant public debate over […] Continue reading -> Urgent Action Needed To End Tuberculosis By 2030, Concludes WHO’s Global Tuberculosis Report 14/10/2020 Svĕt Lustig Vijay The world must take urgent action to end the global tuberculosis epidemic by 2030, especially as the pandemic threatens to unwind hard-won progress made in past decades, concluded the WHO’s 2020 Global Tuberculosis Report on Wednesday. While the WHO European region is on track to achieve key 2020 targets, the rest of the world has […] Continue reading -> Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment 13/10/2020 Editorial team Illustration of the AdVac® adenovirus technology, being tested by Johnson & Johnson, (Credit: J&J) Johnson & Johnson, the only pharma firm currently developing a one-dose COVID-19 vaccine candidate, has “paused” its Phase 3 clinical trial due to an unexplained illness in one of the participants. A press release issued on Monday confirmed reports that a […] Continue reading -> China, Republic of Korea Join COVAX Global Vaccine Pool – WHO Urges Countries To Jumpstart Vaccine Campaigns 09/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin China has announced that it will join the WHO co-sponsored COVAX vaccine procurement pool, along with the Republic of Korea. WHO’s Director General Dr Tedros described it as a major boost to the global effort to manufacture and distribute 2 billion vaccines worldwide equitably by the end of 2021. “This week, China and the Republic […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Ratification of Africa Medicines Agency Treaty Inches Forward – Africa CDC Head Calls It ‘Much-Needed’ 16/10/2020 Paul Adepoju IBADAN, Nigeria – Nearly two years after the Assembly of the African Union, adopted a milestone treaty establishing an African Medicines Agency (AMA) that could provide a more unified approach to regulatory approval of new medicines and vaccines, the AMA treaty is yet to enter into force – because it has not been ratified by […] Continue reading -> China’s Inactivated COVID-19 Vaccine Candidate Is Safe and Provokes Immune Response, Say Preliminary Clinical Trial Results 16/10/2020 Madeleine Hoecklin A new study published in The Lancet on Thursday found that an inactivated vaccine candidate, called BBIBP-CorV, was safe and provoked an immune response in healthy individuals. This is the first study of an inactivated COVID-19 vaccine to include participants over 60 years of age. The BBIBP-CorV vaccine is being developed by the Beijing Institute of […] Continue reading -> World Trade Organization Enters COVID Pandemic Fray With Dispute Brewing Over Patent Rights 14/10/2020 Elaine Ruth Fletcher A safe, proven vaccine for COVID-19 doesn’t yet exist. But the battle for access is heating up. Even as the world struggles to come up with a viable COVID-19 vaccine as well as new treatments, the debate over how to ensure that people around the world can get access to whatever products are available, now […] Continue reading -> The Indian/South African Proposal For a WTO Waiver On IP For COVID-19 Related Health Products – What It Means? 14/10/2020 Ellen 't Hoen A sweeping proposal by India and South Africa to suspend the protection of intellectual property (IP) related to COVID-19 health products is set to come before the The World Trade Organization’s TRIPS Council this week. The closed door discussion lays the groundwork for what could prove to be the most significant public debate over […] Continue reading -> Urgent Action Needed To End Tuberculosis By 2030, Concludes WHO’s Global Tuberculosis Report 14/10/2020 Svĕt Lustig Vijay The world must take urgent action to end the global tuberculosis epidemic by 2030, especially as the pandemic threatens to unwind hard-won progress made in past decades, concluded the WHO’s 2020 Global Tuberculosis Report on Wednesday. While the WHO European region is on track to achieve key 2020 targets, the rest of the world has […] Continue reading -> Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment 13/10/2020 Editorial team Illustration of the AdVac® adenovirus technology, being tested by Johnson & Johnson, (Credit: J&J) Johnson & Johnson, the only pharma firm currently developing a one-dose COVID-19 vaccine candidate, has “paused” its Phase 3 clinical trial due to an unexplained illness in one of the participants. A press release issued on Monday confirmed reports that a […] Continue reading -> China, Republic of Korea Join COVAX Global Vaccine Pool – WHO Urges Countries To Jumpstart Vaccine Campaigns 09/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin China has announced that it will join the WHO co-sponsored COVAX vaccine procurement pool, along with the Republic of Korea. WHO’s Director General Dr Tedros described it as a major boost to the global effort to manufacture and distribute 2 billion vaccines worldwide equitably by the end of 2021. “This week, China and the Republic […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
China’s Inactivated COVID-19 Vaccine Candidate Is Safe and Provokes Immune Response, Say Preliminary Clinical Trial Results 16/10/2020 Madeleine Hoecklin A new study published in The Lancet on Thursday found that an inactivated vaccine candidate, called BBIBP-CorV, was safe and provoked an immune response in healthy individuals. This is the first study of an inactivated COVID-19 vaccine to include participants over 60 years of age. The BBIBP-CorV vaccine is being developed by the Beijing Institute of […] Continue reading -> World Trade Organization Enters COVID Pandemic Fray With Dispute Brewing Over Patent Rights 14/10/2020 Elaine Ruth Fletcher A safe, proven vaccine for COVID-19 doesn’t yet exist. But the battle for access is heating up. Even as the world struggles to come up with a viable COVID-19 vaccine as well as new treatments, the debate over how to ensure that people around the world can get access to whatever products are available, now […] Continue reading -> The Indian/South African Proposal For a WTO Waiver On IP For COVID-19 Related Health Products – What It Means? 14/10/2020 Ellen 't Hoen A sweeping proposal by India and South Africa to suspend the protection of intellectual property (IP) related to COVID-19 health products is set to come before the The World Trade Organization’s TRIPS Council this week. The closed door discussion lays the groundwork for what could prove to be the most significant public debate over […] Continue reading -> Urgent Action Needed To End Tuberculosis By 2030, Concludes WHO’s Global Tuberculosis Report 14/10/2020 Svĕt Lustig Vijay The world must take urgent action to end the global tuberculosis epidemic by 2030, especially as the pandemic threatens to unwind hard-won progress made in past decades, concluded the WHO’s 2020 Global Tuberculosis Report on Wednesday. While the WHO European region is on track to achieve key 2020 targets, the rest of the world has […] Continue reading -> Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment 13/10/2020 Editorial team Illustration of the AdVac® adenovirus technology, being tested by Johnson & Johnson, (Credit: J&J) Johnson & Johnson, the only pharma firm currently developing a one-dose COVID-19 vaccine candidate, has “paused” its Phase 3 clinical trial due to an unexplained illness in one of the participants. A press release issued on Monday confirmed reports that a […] Continue reading -> China, Republic of Korea Join COVAX Global Vaccine Pool – WHO Urges Countries To Jumpstart Vaccine Campaigns 09/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin China has announced that it will join the WHO co-sponsored COVAX vaccine procurement pool, along with the Republic of Korea. WHO’s Director General Dr Tedros described it as a major boost to the global effort to manufacture and distribute 2 billion vaccines worldwide equitably by the end of 2021. “This week, China and the Republic […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
World Trade Organization Enters COVID Pandemic Fray With Dispute Brewing Over Patent Rights 14/10/2020 Elaine Ruth Fletcher A safe, proven vaccine for COVID-19 doesn’t yet exist. But the battle for access is heating up. Even as the world struggles to come up with a viable COVID-19 vaccine as well as new treatments, the debate over how to ensure that people around the world can get access to whatever products are available, now […] Continue reading -> The Indian/South African Proposal For a WTO Waiver On IP For COVID-19 Related Health Products – What It Means? 14/10/2020 Ellen 't Hoen A sweeping proposal by India and South Africa to suspend the protection of intellectual property (IP) related to COVID-19 health products is set to come before the The World Trade Organization’s TRIPS Council this week. The closed door discussion lays the groundwork for what could prove to be the most significant public debate over […] Continue reading -> Urgent Action Needed To End Tuberculosis By 2030, Concludes WHO’s Global Tuberculosis Report 14/10/2020 Svĕt Lustig Vijay The world must take urgent action to end the global tuberculosis epidemic by 2030, especially as the pandemic threatens to unwind hard-won progress made in past decades, concluded the WHO’s 2020 Global Tuberculosis Report on Wednesday. While the WHO European region is on track to achieve key 2020 targets, the rest of the world has […] Continue reading -> Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment 13/10/2020 Editorial team Illustration of the AdVac® adenovirus technology, being tested by Johnson & Johnson, (Credit: J&J) Johnson & Johnson, the only pharma firm currently developing a one-dose COVID-19 vaccine candidate, has “paused” its Phase 3 clinical trial due to an unexplained illness in one of the participants. A press release issued on Monday confirmed reports that a […] Continue reading -> China, Republic of Korea Join COVAX Global Vaccine Pool – WHO Urges Countries To Jumpstart Vaccine Campaigns 09/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin China has announced that it will join the WHO co-sponsored COVAX vaccine procurement pool, along with the Republic of Korea. WHO’s Director General Dr Tedros described it as a major boost to the global effort to manufacture and distribute 2 billion vaccines worldwide equitably by the end of 2021. “This week, China and the Republic […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
The Indian/South African Proposal For a WTO Waiver On IP For COVID-19 Related Health Products – What It Means? 14/10/2020 Ellen 't Hoen A sweeping proposal by India and South Africa to suspend the protection of intellectual property (IP) related to COVID-19 health products is set to come before the The World Trade Organization’s TRIPS Council this week. The closed door discussion lays the groundwork for what could prove to be the most significant public debate over […] Continue reading -> Urgent Action Needed To End Tuberculosis By 2030, Concludes WHO’s Global Tuberculosis Report 14/10/2020 Svĕt Lustig Vijay The world must take urgent action to end the global tuberculosis epidemic by 2030, especially as the pandemic threatens to unwind hard-won progress made in past decades, concluded the WHO’s 2020 Global Tuberculosis Report on Wednesday. While the WHO European region is on track to achieve key 2020 targets, the rest of the world has […] Continue reading -> Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment 13/10/2020 Editorial team Illustration of the AdVac® adenovirus technology, being tested by Johnson & Johnson, (Credit: J&J) Johnson & Johnson, the only pharma firm currently developing a one-dose COVID-19 vaccine candidate, has “paused” its Phase 3 clinical trial due to an unexplained illness in one of the participants. A press release issued on Monday confirmed reports that a […] Continue reading -> China, Republic of Korea Join COVAX Global Vaccine Pool – WHO Urges Countries To Jumpstart Vaccine Campaigns 09/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin China has announced that it will join the WHO co-sponsored COVAX vaccine procurement pool, along with the Republic of Korea. WHO’s Director General Dr Tedros described it as a major boost to the global effort to manufacture and distribute 2 billion vaccines worldwide equitably by the end of 2021. “This week, China and the Republic […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Urgent Action Needed To End Tuberculosis By 2030, Concludes WHO’s Global Tuberculosis Report 14/10/2020 Svĕt Lustig Vijay The world must take urgent action to end the global tuberculosis epidemic by 2030, especially as the pandemic threatens to unwind hard-won progress made in past decades, concluded the WHO’s 2020 Global Tuberculosis Report on Wednesday. While the WHO European region is on track to achieve key 2020 targets, the rest of the world has […] Continue reading -> Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment 13/10/2020 Editorial team Illustration of the AdVac® adenovirus technology, being tested by Johnson & Johnson, (Credit: J&J) Johnson & Johnson, the only pharma firm currently developing a one-dose COVID-19 vaccine candidate, has “paused” its Phase 3 clinical trial due to an unexplained illness in one of the participants. A press release issued on Monday confirmed reports that a […] Continue reading -> China, Republic of Korea Join COVAX Global Vaccine Pool – WHO Urges Countries To Jumpstart Vaccine Campaigns 09/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin China has announced that it will join the WHO co-sponsored COVAX vaccine procurement pool, along with the Republic of Korea. WHO’s Director General Dr Tedros described it as a major boost to the global effort to manufacture and distribute 2 billion vaccines worldwide equitably by the end of 2021. “This week, China and the Republic […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment 13/10/2020 Editorial team Illustration of the AdVac® adenovirus technology, being tested by Johnson & Johnson, (Credit: J&J) Johnson & Johnson, the only pharma firm currently developing a one-dose COVID-19 vaccine candidate, has “paused” its Phase 3 clinical trial due to an unexplained illness in one of the participants. A press release issued on Monday confirmed reports that a […] Continue reading -> China, Republic of Korea Join COVAX Global Vaccine Pool – WHO Urges Countries To Jumpstart Vaccine Campaigns 09/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin China has announced that it will join the WHO co-sponsored COVAX vaccine procurement pool, along with the Republic of Korea. WHO’s Director General Dr Tedros described it as a major boost to the global effort to manufacture and distribute 2 billion vaccines worldwide equitably by the end of 2021. “This week, China and the Republic […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
China, Republic of Korea Join COVAX Global Vaccine Pool – WHO Urges Countries To Jumpstart Vaccine Campaigns 09/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin China has announced that it will join the WHO co-sponsored COVAX vaccine procurement pool, along with the Republic of Korea. WHO’s Director General Dr Tedros described it as a major boost to the global effort to manufacture and distribute 2 billion vaccines worldwide equitably by the end of 2021. “This week, China and the Republic […] Continue reading -> Posts navigation Older postsNewer posts